INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)
BEERSE, Belgium, May 31, 2013/PRNewswire –
–INCIVO® triple therapy now offers a twice daily HCV treatment regimen which should improve patient adherence[1] –
Janssen Infectious Diseases-Diagnostics BVBA (Janssen) announced today that the